Zacks Investment Research upgraded shares of Select Medical (NYSE:SEM) from a sell rating to a hold rating in a research note published on Saturday morning.
According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “
Several other research firms have also recently weighed in on SEM. ValuEngine cut shares of Select Medical from a buy rating to a hold rating in a research report on Monday, October 2nd. Robert W. Baird set a $25.00 price objective on shares of Select Medical and gave the stock a buy rating in a research report on Monday, October 23rd. Royal Bank of Canada reiterated a buy rating and set a $19.00 price objective on shares of Select Medical in a research report on Friday, October 13th. Deutsche Bank reiterated a buy rating and set a $22.00 price objective on shares of Select Medical in a research report on Monday, November 6th. Finally, Bank of America upgraded shares of Select Medical from an underperform rating to a neutral rating and set a $19.00 price objective on the stock in a research report on Thursday, January 4th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of Hold and an average price target of $19.43.
Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.02). Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The firm had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter in the previous year, the firm posted $0.06 earnings per share. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. equities research analysts expect that Select Medical will post 0.86 earnings per share for the current fiscal year.
In other Select Medical news, insider Scott A. Romberger sold 5,000 shares of Select Medical stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total transaction of $89,850.00. Following the completion of the sale, the insider now owns 168,211 shares of the company’s stock, valued at approximately $3,022,751.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Michael E. Tarvin sold 18,500 shares of Select Medical stock in a transaction on Monday, October 30th. The shares were sold at an average price of $18.97, for a total transaction of $350,945.00. Following the sale, the insider now directly owns 340,044 shares of the company’s stock, valued at approximately $6,450,634.68. The disclosure for this sale can be found here. Insiders have sold a total of 314,455 shares of company stock valued at $5,403,144 in the last three months. Company insiders own 19.93% of the company’s stock.
Large investors have recently modified their holdings of the business. Parametric Portfolio Associates LLC boosted its stake in shares of Select Medical by 3.0% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 390,052 shares of the health services provider’s stock valued at $5,987,000 after buying an additional 11,245 shares during the period. Russell Investments Group Ltd. boosted its stake in shares of Select Medical by 121.5% during the 2nd quarter. Russell Investments Group Ltd. now owns 85,912 shares of the health services provider’s stock valued at $1,319,000 after buying an additional 47,131 shares during the period. Parametrica Management Ltd acquired a new stake in shares of Select Medical in the 3rd quarter valued at $653,000. Chicago Equity Partners LLC acquired a new stake in shares of Select Medical in the 3rd quarter valued at $1,105,000. Finally, Affinity Wealth Management acquired a new stake in shares of Select Medical in the 3rd quarter valued at $429,000. 77.89% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: “Select Medical (SEM) Upgraded to “Hold” at Zacks Investment Research” was first reported by Markets Daily and is owned by of Markets Daily. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://www.themarketsdaily.com/2018/01/10/select-medical-sem-upgraded-to-hold-at-zacks-investment-research.html.
Select Medical Company Profile
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.